Harvest Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Harvest Capital Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-41,900	Closed	-$1.96M	–	86
2014 Q1	$1.96M	Sell	41,900 -2,300	-5%	-$109K	0.93%	22
2013 Q4	$1.94M	Sell	44,200 -400	-0.9%	-$16.7K	1.01%	21
2013 Q3	$1.72M	Sell	44,600 -550	-1%	-$20.8K	1.05%	21
2013 Q2	$1.59M	Buy	+45,150	New	+$1.52M	1.19%	20

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Harvest Capital Management's XPH Position: Q2 2014 in Review

Harvest Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2014, closing a stake of 41,900 shares — an estimated $1.96M sold.

Harvest Capital Management first reported a position in XPH in Q2 2013 and held it in 4 quarters. The position peaked at $1.96M in Q1 2014. 69 funds tracked by Wall St. Rank hold XPH as of Q2 2014.

Harvest Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2014 after selling out during the quarter.
Harvest Capital Management sold 41,900 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2014, an estimated $1.96M.
Harvest Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 4 quarters.
Harvest Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.96M in Q1 2014.
69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2014.

Based on Harvest Capital Management's 13F filing for Q2 2014, filed 29 Jul 2014.